Literature DB >> 7989878

The epidemiology of male adolescent low back pain in a north suburban population of Melbourne, Australia.

P S Ebrall1.   

Abstract

OBJECTIVE: To determine the prevalence of low back pain (LBP) in an Australian metropolitan, male adolescent population.
DESIGN: Self-reported, pretested questionnaire that included a definition of LBP and a description of the body area it affects.
SETTING: Three government operated secondary schools in a growth corridor of north suburban Melbourne, Australia.
SUBJECTS: Six hundred ten males attending secondary (high) school, aged between 12 and 19 yr. INTERVENTION: None. MAIN OBSERVATIONS: The point prevalence of LBP was found to be 16.7% and the sample prevalence 57%. The typical sufferer of adolescent LBP (ALBP) reported chronic LBP experienced up to a few days at a time, several times a month.
CONCLUSIONS: The high prevalence of ALBP found by studies in other populations is confirmed in Australia. There is a clear need for further study of the etiology and potential preventative factors of ALBP, and for consideration of whether nontraumatic occupational LBP results more from an aggravation of a preexisting (adolescent) condition than from an unsafe or unsuitable work environment.

Entities:  

Mesh:

Year:  1994        PMID: 7989878

Source DB:  PubMed          Journal:  J Manipulative Physiol Ther        ISSN: 0161-4754            Impact factor:   1.437


  3 in total

1.  Child labor and musculoskeletal disorders: the Pelotas (Brazil) epidemiological survey.

Authors:  Anaclaudia Gastal Fassa; Luiz Augusto Facchini; Marinel Mór Dall'Agnol; David C Christiani
Journal:  Public Health Rep       Date:  2005 Nov-Dec       Impact factor: 2.792

2.  What is adolescent low back pain? Current definitions used to define the adolescent with low back pain.

Authors:  Steven Milanese; Karen Grimmer-Somers
Journal:  J Pain Res       Date:  2010-05-17       Impact factor: 3.133

Review 3.  Prevalence of low back pain in children and adolescents: a meta-analysis.

Authors:  Inmaculada Calvo-Muñoz; Antonia Gómez-Conesa; Julio Sánchez-Meca
Journal:  BMC Pediatr       Date:  2013-01-26       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.